Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection
E. Gupta et al. Journal of Clinical Virology 88 (2017) 46–51
Jan
2019
Molecular testing atthe point-of-care may turn outto be game changer for HCVdiagnosis and treatment monitoring, through increased sensitivity, reduced turnaround time, and ease of performance. One such assay GeneXpert® has recently been released. Comparative analysis between performances of GeneXpert® and Abbott HCV-RNA was done
The selected activity requires you to open a PDF document from an external website.
Click the button below to open the requested document in a new browser tab or window.
To return to this page, switch back to this browser tab, or close the newly opened page.
Open "Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection"
